Fore Biotherapeutics
A precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics
Philadelphia, United States
46 employees
Series D
Total: $166.50M
Biotechnology, Health Care
General Information
Philadelphia, United States
BounceWatch is an independent company data service, not affiliated with Fore Biotherapeutics. To contact Fore Biotherapeutics, visit fore.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Fore Biotherapeutics compare?
A PDF of Fore Biotherapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Fore Biotherapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Fore Biotherapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Fore Biotherapeutics
Business keywords: precision oncology, cancer therapies, functional genomics, science, innovation, precision medicine, oncology research, drug development, cancer treatment, precision medicine company
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | $75.00M | 9 |
|
23 Aug 2023 |
| Convertible Note | Undisclosed | 2 |
|
17 Oct 2022 |
| Series C | Undisclosed | 2 |
|
15 Sep 2021 |
| Series C | $57.00M | 7 |
|
21 Sep 2020 |
| Venture Round | $6.00M | 4 |
|
30 Apr 2018 |
| Venture Round | $2.50M | 1 |
|
22 Jun 2016 |
| Venture Round | $10.00M | 1 |
InterCure
|
23 Dec 2015 |
| Seed Round | $8.00M | - |
|
01 Jul 2014 |
| Seed Round | $8.00M | - |
|
01 Jul 2013 |
Fore Biotherapeutics Alternatives & Competitors
View All Alternatives
Pioneering the Next Generation of Precision Oncology
Leading the new frontier of targeted cancer therapies exploiting tumors’ genetic vulnerabilities.
We are focused on discovering and developing selective cancer therapies to treat patients across a r...
FAQ About Fore Biotherapeutics
Source: BounceWatch company record for Fore Biotherapeutics, https://bouncewatch.com/company/fore-biotherapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
